Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of entecavir 0.5 mg tablets in healthy Thai volunteers under fasting conditions
TCTR20191216002Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of entecavir in hepatitis B (HBV) (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax and Truncated AUC0-72. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on TCTR20191216002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20191216002.